US$ 22.11
icer glp 1 Incremental cost-effectiveness ratio (ICER) scatterplot comparing newer Affordable Access to GLP-1 Obesity
Description
doi: 10.1139/y03-107

Soc Personal Psychol Compass

Both are sold by Danish drug giant Novo Nordisk
What the FDA documented here is alarming on its own terms
